Industry News
LegoChem and Iksuda expand license agreement for development of antibody-drug conjugates
The expanded agreement grants Iksuda access to LegoChem Biosciences’ next generation ADC platform for up to six targets
News & Articles
25
The expanded agreement grants Iksuda access to LegoChem Biosciences’ next generation ADC platform for up to six targets
